Nervous System News and Research

Latest Nervous System News and Research

Novel therapy technique double rate of upper limb recovery in stroke patients

A novel therapy technique invented by researchers at The University of Texas at Dallas has been shown in a pilot study to double the rate of upper limb recovery in stroke patients, a leap forward in treating the nearly 800,000 Americans who suffer strokes each year.

27 Sep 2018

New drug to treat Parkinson's disease psychosis do not pose greater risk of death

In the wake of media and public reports about increased mortality linked to a new drug for treating Parkinson's disease psychosis -- a symptom of the progressive nervous system disorder in which patients experience hallucinations and delusions -- researchers at University of California San Diego School of Medicine conducted a retrospective study of qualifying patients in the UC San Diego Health system, concluding that the new drug, pimavanserin, did not pose a statistically significant greater risk of death.

27 Sep 2018

Obese mothers who underwent bariatric surgery can have safer deliveries

Obese mothers who lose weight through bariatric surgery can have safer deliveries. The positive effects are many, including fewer cesarean sections, infections, tears and hemorrhages, and fewer cases of post-term delivery or uterine inertia.

27 Sep 2018

Olfactory cells could act as 'Trojan horse,' delivering anticancer therapy to dangerous brain tumors

A special type of cell essential to the ability of olfactory neurons to regenerate may be genetically engineered to deliver anticancer therapy to the dangerous brain tumors called glioblastomas.

27 Sep 2018

New EU project aims to learn more about hormone-disrupting chemicals

Hormone-disrupting chemicals in our environment can affect early neurodevelopment in children, but little is known about the exact mechanisms for this interference. A new EU funded research project, coordinated from Karolinska Institutet, now aims to learn more and to develop better screening and testing tools.

26 Sep 2018

Study reveals changes in functioning of older individuals’ central nervous system

The central nervous system of older individuals responds to movement and initiates muscular contraction differently compared to young individuals.

26 Sep 2018

Risk-profiling can help improve preventive measures against HIV

That men who have sex with men run a greater risk of HIV than others has been known since the virus was discovered. However a thesis from Karolinska Institutet now shows that it is a small sub-group of these men who account for the greater part of the risk increase.

26 Sep 2018

Researchers to explore sex differences in cardiovascular and renal physiology

A person's sex can be a defining factor in how well--or how poorly--they respond to disease, therapy and recovery. Experts at the forefront of sex-specific research will convene next week at the sixth APS conference on sex differences in cardiovascular and renal physiology.

26 Sep 2018

Cerevance starts dosing in Phase I clinical trial of CVN424 for treatment of Parkinson's disease

Cerevance, a clinical-stage drug discovery and development company focused on brain diseases, today announced the start of dosing in a Phase I first-in-human clinical trial of CVN424, an oral compound being developed for symptomatic treatment of Parkinson's disease.

25 Sep 2018

Activation of glial cells causes inflammation in the brain of fibromyalgia patients

The causes of the difficult-to-treat pain syndrome fibromyalgia are largely unknown. Using PET brain imaging, researchers at Karolinska Institutet and Harvard University have now shown that glial cells - the central nervous system's immune cells - are activated in the brains of patients with fibromyalgia. The finding opens the way for new therapies

25 Sep 2018

Researchers develop way to measure different types of fear of falling in patients with Parkinson’s

Parkinson's disease, a progressive nervous system disorder that affects movement, causes one of the highest risks of falling among all neurological conditions. Due to this, many patients develop a fear of falling, even if they have never fallen.

25 Sep 2018

New research finds link between impaired vision, hearing, and cognition

Experts at a prestigious medical conference hosted by the American Geriatrics Society and funded by the National Institute on Aging hope their work--reported today in the Journal of the American Geriatrics Society--will have colleagues seeing eye-to-eye on an important but under-researched area of health care: The link between impaired vision, hearing, and cognition

25 Sep 2018

Phase 1 and 2 clinical trials of entrectinib drug in ROS1-positive NSCLC show promising results

Results of phase 1 and phase 2 clinical trials of the drug entrectinib in ROS1-positive non-small cell lung cancer presented on the press program of the International Association for the Study of Lung Cancer 19th World Conference on Lung Cancer show a response rate of 77.4 percent for 53 patients evaluable for response, with median duration of response of 24.6 months.

25 Sep 2018

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

Alexion Pharmaceuticals, Inc. today announced positive topline results from the Phase 3 PREVENT study of Soliris in patients with anti-aquaporin-4 auto antibody-positive neuromyelitis optica spectrum disorder.

24 Sep 2018

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

Seattle Genetics, Inc. today announced that its collaborator, Takeda Pharmaceutical Company Limited, has received approval from the Japanese Ministry of Health, Labour and Welfare for ADCETRIS (brentuximab vedotin) in combination with doxorubicin, vinblastine and dacarbazine as a frontline treatment option for CD30-positive Hodgkin lymphoma patients in Japan.

24 Sep 2018

CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents

Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Gilenya (fingolimod) for the treatment of children and adolescents 10 to 17 years of age with relapsing remitting forms of multiple sclerosis.

24 Sep 2018

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion, recommending the full approval of ALUNBRIG® as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer previously treated with crizotinib.

24 Sep 2018

Study offers solid link between visceral organs and brain’s reward, motivation system

A novel gut-to-brain neural circuit establishes the vagus nerve as an essential component of the brain system that regulates reward and motivation, according to research conducted at the Icahn School of Medicine at Mount Sinai and published September 20 in the journal Cell.

21 Sep 2018

Sea squirt model reveals key molecules in dopaminergic neuron differentiation

The human brain is exceedingly complex, consisting of various regions with particular functions and approximately 100 billion neurons. This complexity has presented a major challenge in understanding this organ and how it develops, particularly in view of the ethical issues associated with research on humans.

20 Sep 2018

Eating fatty fish during pregnancy may boost unborn child's brain development

Women could enhance the development of their unborn child's eyesight and brain function by regularly eating fatty fish during pregnancy.

20 Sep 2018

Nervous System News and Research

Latest Nervous System News and Research

Novel therapy technique double rate of upper limb recovery in stroke patients

New drug to treat Parkinson's disease psychosis do not pose greater risk of death

Obese mothers who underwent bariatric surgery can have safer deliveries

Olfactory cells could act as 'Trojan horse,' delivering anticancer therapy to dangerous brain tumors

New EU project aims to learn more about hormone-disrupting chemicals

Study reveals changes in functioning of older individuals’ central nervous system

Risk-profiling can help improve preventive measures against HIV

Researchers to explore sex differences in cardiovascular and renal physiology

Cerevance starts dosing in Phase I clinical trial of CVN424 for treatment of Parkinson's disease

Activation of glial cells causes inflammation in the brain of fibromyalgia patients

Researchers develop way to measure different types of fear of falling in patients with Parkinson’s

New research finds link between impaired vision, hearing, and cognition

Phase 1 and 2 clinical trials of entrectinib drug in ROS1-positive NSCLC show promising results

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

Study offers solid link between visceral organs and brain’s reward, motivation system

Sea squirt model reveals key molecules in dopaminergic neuron differentiation

Eating fatty fish during pregnancy may boost unborn child's brain development

Everything you need to know about epilepsy eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Nervous System News and Research

Latest Nervous System News and Research

Everything you need to know about epilepsy eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in